The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Myeloma developing regimens using genomics (MyDRUG) trial: Results from the RAS mutation targeting arm.
 
Shaji Kumar
Honoraria - BeiGene
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Cellectar; Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
Giada Bianchi
No Relationships to Disclose
 
Noa Biran
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Oncopeptides; Pfizer; Takeda
Consulting or Advisory Role - Amgen; Celgene; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Oncopeptides; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Karyopharm Therapeutics (Inst); Merck (Inst)
 
Malin Hultcrantz
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Bristol-Myers Squibb/Celgene; Curio Science; Intellisphere
Research Funding - Amgen (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst)
 
Joshua Ryan Richter
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Antengene; Celgene; Karyopharm Therapeutics; Oncopeptides; Sanofi; Secura Bio; Takeda; X4 Pharma
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Janssen
 
Ravi Vij
Consulting or Advisory Role - Adaptive Biotechnologies; BeiGene; Bristol-Myers Squibb/Celgene; CareDX; GlaxoSmithKline; harpoon; Legend Biotech; Oncopeptides; Pfizer; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Dava Oncology; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
 
Jing Christine Ye
No Relationships to Disclose
 
Jeffrey A. Zonder
No Relationships to Disclose
 
Lauren DiLello
No Relationships to Disclose
 
Jen Yesil
No Relationships to Disclose
 
Hearn J. Cho
Employment - Multiple Myeloma Research Foundation
Research Funding - Bristol-Myers Squibb; Takeda